Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;17(4):183-188.
doi: 10.5114/kitp.2020.102340. Epub 2021 Jan 15.

Use of the six-minute walk test in exercise prescription in male patients after coronary artery bypass surgery

Dorota Dolecińska  1 , Izabela Przywarska  2 , Tomasz Podgórski  3 , Piotr Dylewicz  4 , Jacek Lewandowski  1
Affiliations

Use of the six-minute walk test in exercise prescription in male patients after coronary artery bypass surgery

Dorota Dolecińska et al. Kardiochir Torakochirurgia Pol. 2020 Dec.

Abstract

Introduction: It is unclear whether it is possible to determine the training load on the basis of the 6-minute walk test (6-MWT) in patients after cardiac surgery with low tolerance of physical exercise.

Aim: Use of the 6-MWT to determine an individual initial training load in walking training on a treadmill in the early phase of cardiac rehabilitation in men after coronary artery bypass graft (CABG) surgery.

Material and methods: Twenty-two men aged 54 to 74 years, up to 3 months after CABG surgery participated in walking training on a treadmill (12-15 sessions). Patients underwent the initial and final treadmill exercise stress test (TEST) and the 6-MWT. Based on 6-MWT results, the initial training load was prescribed. Before the 6-MWT and 3 minutes after its completion, lactate concentration was determined.

Results: The 6-MWT distance increased from 420 ±80 m to 519 ±61 m (p < 0.001), and the energy expenditure from 4.4 ±1.4 MET to 6.3 ±1.3 MET (p < 0.001). There was a positive correlation between 6-MWT distance and energy expenditure in the TEST before rehabilitation (r = 0.60, p = 0.005), and after rehabilitation (r = 0.75, p < 0.001). A negative correlation was found between the baseline 6-MWT distance and distance increment in the final 6-MWT (r = -0.66, p = 0.002). The 6-MWT did not induce hyperlactatemia.

Conclusions: The 6-MWT can be used in exercise intensity prescription, especially for determining the individual initial training load, load progression, as well as its correction during follow-up tests.

Keywords: 6-minute walk test; cardiac rehabilitation; coronary artery bypass; lactate; walking training.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflict of interest.

Figures

Figure 1
Figure 1
Speed of walking during treadmill walking training sessions
Figure 2
Figure 2
Relationship between 6-minute walk test (6-MWT) distance and energy expenditure in TEST before rehabilitation (r – Pearson correlation coefficient)
Figure 3
Figure 3
Relationship between 6-minute walk test (6-MWT) distance and energy expenditure in TEST after rehabilitation (r – Pearson correlation coefficient)
Figure 4
Figure 4
Relationship between 6-minute walk test (6-MWT) distance before rehabilitation and 6-MWT distance increment after rehabilitation (r – Pearson correlation coefficient)
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Taylor A, Yang E. Comparing American and European guidelines for the initial diagnosis of stable ischaemic heart disease. Eur Heart J. 2020;41:811–815. - PubMed
    1. Mytinger M, Nelson RK, Zuhl M. Exercise prescription guidelines for cardiovascular disease patients in the absence of a baseline stress test. J Cardiovasc Dev Dis. 2020;7:E15. - PMC - PubMed
    1. Casillas JM, Gudjoncik A, Gremeaux V, Aulagne J, Besson D, Laroche D. Assessment tools for personalizing training intensity during cardiac rehabilitation: literature review and practical proposals. Ann Phys Rehabil Med. 2017;60:43–49. - PubMed
    1. Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, Federici M, Filippatos G, Grobbee DE, Hansen TB, Huikuri HV, Johansson I, Jüni P, Lettino M, Marx N, Mellbin LG, Östgren CJ, Rocca B, Roffi M, Sattar N, Seferović PM, Sousa-Uva M, Valensi P, Wheeler DC. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41:255–323. - PubMed
    1. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, Prescott E, Storey RF, Deaton C, Cuisset T, Agewall S, Dickstein K, Edvardsen T, Escaned J, Gersh BJ, Svitil P, Gilard M, Hasdai D, Hatala R, Mahfoud F, Masip J, Muneretto C, Valgimigli M, Achenbach S, Bax JJ. 2019 ESC Guidelines for the Diagnosis and Management of Chronic Coronary Syndromes. Eur Heart J. 2020;41:407–477. - PubMed